Product NDC: | 0009-0760 |
Proprietary Name: | Cleocin Pediatric |
Non Proprietary Name: | clindamycin palmitate hydrochloride |
Active Ingredient(s): | 75 mg/5mL & nbsp; clindamycin palmitate hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0760 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA061772 |
Marketing Category: | ANDA |
Start Marketing Date: | 19710916 |
Package NDC: | 0009-0760-04 |
Package Description: | 75 mL in 1 BOTTLE (0009-0760-04) |
NDC Code | 0009-0760-04 |
Proprietary Name | Cleocin Pediatric |
Package Description | 75 mL in 1 BOTTLE (0009-0760-04) |
Product NDC | 0009-0760 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin palmitate hydrochloride |
Dosage Form Name | GRANULE, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19710916 |
Marketing Category Name | ANDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |